GOOD ADHERENCE OF RHEUMATOLOGISTS TO A 10 YEAR TREAT-TO-TARGET PROTOCOL FOR PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS (THE BEST STUDY)